These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

332 related items for PubMed ID: 32682086

  • 1. Hepatic transcriptome signature correlated with HOMA-IR explains early nonalcoholic fatty liver disease pathogenesis.
    Chatterjee A, Basu A, Das K, Singh P, Mondal D, Bhattacharya B, Roychoudhury S, Majumder PP, Chowdhury A, Basu P.
    Ann Hepatol; 2020; 19(5):472-481. PubMed ID: 32682086
    [Abstract] [Full Text] [Related]

  • 2. Hepatic transcriptome signatures in patients with varying degrees of nonalcoholic fatty liver disease compared with healthy normal-weight individuals.
    Suppli MP, Rigbolt KTG, Veidal SS, Heebøll S, Eriksen PL, Demant M, Bagger JI, Nielsen JC, Oró D, Thrane SW, Lund A, Strandberg C, Kønig MJ, Vilsbøll T, Vrang N, Thomsen KL, Grønbæk H, Jelsing J, Hansen HH, Knop FK.
    Am J Physiol Gastrointest Liver Physiol; 2019 Apr 01; 316(4):G462-G472. PubMed ID: 30653341
    [Abstract] [Full Text] [Related]

  • 3. A longitudinal study of whole body, tissue, and cellular physiology in a mouse model of fibrosing NASH with high fidelity to the human condition.
    Krishnan A, Abdullah TS, Mounajjed T, Hartono S, McConico A, White T, LeBrasseur N, Lanza I, Nair S, Gores G, Charlton M.
    Am J Physiol Gastrointest Liver Physiol; 2017 Jun 01; 312(6):G666-G680. PubMed ID: 28232454
    [Abstract] [Full Text] [Related]

  • 4. Clinical validation of the FLIP algorithm and the SAF score in patients with non-alcoholic fatty liver disease.
    Nascimbeni F, Bedossa P, Fedchuk L, Pais R, Charlotte F, Lebray P, Poynard T, Ratziu V, LIDO (Liver Injury in Diabetes and Obesity) Study Group.
    J Hepatol; 2020 May 01; 72(5):828-838. PubMed ID: 31862486
    [Abstract] [Full Text] [Related]

  • 5. Nonalcoholic Fatty Liver Disease and Staging of Hepatic Fibrosis.
    Engin A.
    Adv Exp Med Biol; 2024 May 01; 1460():539-574. PubMed ID: 39287864
    [Abstract] [Full Text] [Related]

  • 6. Insulin resistance, but not insulin response, during oral glucose tolerance test (OGTT) is associated to worse histological outcome in obese NAFLD.
    Coccia F, Testa M, Guarisco G, Di Cristofano C, Silecchia G, Leonetti F, Gastaldelli A, Capoccia D.
    Nutr Metab Cardiovasc Dis; 2020 Jan 03; 30(1):106-113. PubMed ID: 31677889
    [Abstract] [Full Text] [Related]

  • 7. Bioinformatics analysis reveals novel core genes associated with nonalcoholic fatty liver disease and nonalcoholic steatohepatitis.
    Feng G, Li XP, Niu CY, Liu ML, Yan QQ, Fan LP, Li Y, Zhang KL, Gao J, Qian MR, He N, Mi M.
    Gene; 2020 Jun 05; 742():144549. PubMed ID: 32184169
    [Abstract] [Full Text] [Related]

  • 8. Adipocytokines and cytokeratin-18 in patients with nonalcoholic fatty liver disease: Introduction of CHA index.
    Polyzos SA, Kountouras J, Papatheodorou A, Katsiki E, Patsiaoura K, Zafeiriadou E, Papadopoulou E, Zavos C, Terpos E.
    Ann Hepatol; 2013 Jun 05; 12(5):749-57. PubMed ID: 24067262
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Ultra-high-field magnetic resonance spectroscopy in non-alcoholic fatty liver disease: Novel mechanistic and diagnostic insights of energy metabolism in non-alcoholic steatohepatitis and advanced fibrosis.
    Traussnigg S, Kienbacher C, Gajdošík M, Valkovič L, Halilbasic E, Stift J, Rechling C, Hofer H, Steindl-Munda P, Ferenci P, Wrba F, Trattnig S, Krššák M, Trauner M.
    Liver Int; 2017 Oct 05; 37(10):1544-1553. PubMed ID: 28544208
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. The role of bariatric surgery on beta-cell function and insulin resistance in patients with nonalcoholic fatty liver disease and steatohepatitis.
    Poljo A, Kopf S, Sulaj A, Roessler S, Albrecht T, Goeppert B, Bojko S, Müller-Stich BP, Billeter AT.
    Surg Obes Relat Dis; 2023 Dec 05; 19(12):1421-1434. PubMed ID: 37666725
    [Abstract] [Full Text] [Related]

  • 13. Hepatic FATP5 expression is associated with histological progression and loss of hepatic fat in NAFLD patients.
    Enooku K, Tsutsumi T, Kondo M, Fujiwara N, Sasako T, Shibahara J, Kado A, Okushin K, Fujinaga H, Nakagomi R, Minami T, Sato M, Uchino K, Nakagawa H, Kondo Y, Asaoka Y, Tateishi R, Ueki K, Ikeda H, Yoshida H, Moriya K, Yotsuyanagi H, Kadowaki T, Koike K.
    J Gastroenterol; 2020 Feb 05; 55(2):227-243. PubMed ID: 31602526
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. The American lifestyle-induced obesity syndrome diet in male and female rodents recapitulates the clinical and transcriptomic features of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis.
    Harris SE, Poolman TM, Arvaniti A, Cox RD, Gathercole LL, Tomlinson JW.
    Am J Physiol Gastrointest Liver Physiol; 2020 Sep 01; 319(3):G345-G360. PubMed ID: 32755310
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Lipid oxidation products in the pathogenesis of non-alcoholic steatohepatitis.
    Bellanti F, Villani R, Facciorusso A, Vendemiale G, Serviddio G.
    Free Radic Biol Med; 2017 Oct 01; 111():173-185. PubMed ID: 28109892
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.